Arcagy/ Gineco Group

This study tested whether adding immunotherapy drugs to standard chemotherapy before surgery is safe and feasible for patients with advanced ovarian cancer. The trial involved 69 women with newly diagnosed, advanced ovarian, fallopian tube, or primary peritoneal cancer who were n…

This study compared whether performing surgery after 3 rounds of chemotherapy or after 6 rounds works better for women with advanced ovarian cancer who weren't suitable for immediate surgery. Researchers wanted to see which timing led to longer periods without cancer returning an…

This study tested if adding the immunotherapy drug pembrolizumab (Keytruda) to standard chemotherapy before surgery could better control advanced ovarian cancer that couldn't be operated on right away. It involved 91 women with stage IV disease. The goal was to see if the combina…

This study aims to understand how specific genetic changes in ovarian, fallopian tube, or peritoneal cancer affect how the disease progresses and responds to treatment. Researchers will collect medical information and tumor samples from 1500 French patients with advanced-stage ca…